July 11, 2011 08:30 ET
SAN DIEGO, CA–(Marketwire – Jul 11, 2011) – Medical Marijuana Inc (PINKSHEETS: MJNA) announced today that as of August 1, 2011 its initial Cannabidiol (CBD) Product lines will be available for consumers in the United States.
The first lines of products are to be distributed to more than two thousand health and wellness centers throughout the United States as well as direct to consumers through the Hemp Network, a division of Medical Marijuana Inc (www.thehempnetwork.com). The products will be available in a CBD tablet, CBD capsule, and CBD-infused beverage line, all which carry the health and wellness benefits of CBD cannabis extract.
For more information about the health benefits of Cannabidiol (CBD) please visit the following United States Health Department Patent # 6,630,507, titled “Cannabis as Antioxidants and Neuroprotectants” (see http://tinyurl.com/6hwwmt). This article explains many of the benefits of Cannabis and specifically Cannabidiol (CBD).
Medical Marijuana Inc is reviewing the previous offers from distributors for these products in China and Europe, negotiations are expected to conclude by August 1, 2011.
ABOUT MEDICAL MARIJUANA INC
Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.